Highest-materiality recent filing
Medical Properties Trust Q1 net income $0.05/shr vs loss last year; NFFO $0.14/shr steady
Net income $33M ($0.05 per share) vs net loss of $118M ($0.20) in Q1 2025.
MPT Q4 net income $0.03/sh, NFFO $0.18/sh; portfolio reshaping with new leases and acquisitions
Net income $17M ($0.03/sh) in Q4 2025 vs net loss ($413M) in Q4 2024; full-year net loss ($277M) vs ($2.4B).
Net loss $78M ($0.13/sh) vs $801M loss year ago; NFFO $77M ($0.13/sh) vs $94M ($0.16/sh) year ago.
MPT enters $500M ATM equity distribution agreement with multiple underwriters
Common stock may be sold via agents or forward sale transactions up to $500M aggregate offering price.
Net loss per share ($0.16) vs ($0.54) a year ago; NFFO $0.14 vs $0.23.
MPT Q1 net loss narrows to $0.20/share; NFFO falls to $0.14 on impairments and higher interest
Net loss per share ($0.20) vs ($1.46) a year ago; includes $73M in impairments related to Prospect Medical and PHP.
Medical Properties Trust Q4 net loss $0.69/share; completes $2.5B secured notes offering
Net loss of $0.69 per share includes ~$415M impairments on Prospect Medical and PHP.
Issued $1.5B 8.5% and €1B 7% senior secured notes due 2032; interest starts Aug 15, 2025.
MPT prices $1.5B USD 8.5% and €1.0B 7.0% senior secured notes due 2032
Blended coupon of 7.885%; sizes revised from $2B/€500M to $1.5B/€1.0B.
MPT launches up to $2.0B+ senior secured notes; redeems $1.7B+ in existing notes
Offers up to $2.0B USD and €500M senior secured notes due 2032.
MPT reports Q3 net loss $1.34/sh, NFFO $0.16/sh; Steward re-tenanting progressing
Net loss of $801M ($1.34/sh) vs net income $117M ($0.19/sh) in Q3 2023; NFFO fell to $0.16/sh from $0.38/sh.
Bankruptcy court approves Steward settlement; MPT re-leases 15 hospitals, expects $430M impairment
Bankruptcy court approved interim global settlement terminating Steward master lease; 15 hospitals transitioned to new interim managers designated by MPT as of Sept 11, 2024.
MPT reports Q2 net loss $0.54/share, cuts cash dividend to $0.08, amends credit facility
Net loss of ($321M) or ($0.54)/share; NFFO $139M ($0.23)/share vs $285M ($0.48) prior year.
MPW records additional $140M fair value write-down on PHP Holdings investment to ~$500M
Additional $140M unfavorable fair value adjustment to PHP Holdings investment, bringing total to ~$500M as of March 31, 2024.
MPT secures £631M ($800M) secured term loan at 6.877% over 10 years
Loan of £631M ($800M) secured by 27 UK properties leased to Circle Health Holdings affiliates; fixed rate 6.877%.
MPT receives NYSE non-compliance notice for delayed Q1 10-Q; six-month cure period
Received NYSE notice on May 16, 2024 for failure to timely file Q1 2024 Form 10-Q.
MPT records additional $470M impairment on Steward investments after Ch. 11 filing
Steward Health Care filed Chapter 11 on May 6; MPT had ~$2.4B master lease, $406M JV, $708M loans, and 9.9% equity.
MPT reports Q1 net loss of $1.23/sh, $693M impairments; Steward bankruptcy, $75M DIP
Net loss of $736M ($1.23/sh) vs net income $33M ($0.05/sh) in Q1 2023; NFFO $0.24/sh vs $0.37/sh.
Steward Health Care files Ch. 11; MPW holds $362M loan, leases 36 facilities
Steward filed Chapter 11 on May 6, 2024; two master leases with MPW expire Oct 2041 cover 36 facilities.
MPT sells majority stake in five Utah hospitals for ~$1.1B cash; repays Australian term loan
Sold interests in five Utah hospitals to JV with Blue Owl RE Nucleus; retained ~25% stake.
MPW posts Q4 net loss of $664M ($1.11/shr); includes $772M Steward impairments
Q4 2023 NFFO of $0.36/shr; full-year NFFO $1.59/shr, down from $1.82/shr in 2022.
MPT expects $350M write-off of Steward rent receivables; provides $60M bridge loan
Unpaid rent under Steward master lease totals ~$50M as of Dec 31, 2023 (excl. ~$50M Norwood deferred).
MPT reports Q3 net income $0.19/share; plans $2B liquidity raise to repay debt
Net income $117M ($0.19/diluted share) vs $222M ($0.37) a year ago; NFFO $226M ($0.38) vs $272M ($0.45).
MPT Q2 net loss $0.07/shr; NFFO $0.48; narrows 2023 outlook
Net loss of $42M ($0.07/shr) vs income $190M ($0.32) YoY; includes $286M accelerated amortization and $95M rent write-off.
MPT: Prospect completes $375M recap, $250M ABL repaid; Australian hospital sale delayed to Q3 2023
Prospect's $250M ABL facility fully repaid; $75M MPT delayed-draw term loan now secured by receivables.
Net income $33M ($0.05/diluted) vs $632M ($1.05) in Q1 2022; includes $90M impairment for hospital sales.
MPT responds to WSJ article on $300M lease intangible; expects no FFO impact from acceleration
Approximately $300M in-place lease intangible tied to Steward lease; amortization may be accelerated if lease terminates.
MPT files defamation lawsuit against Viceroy Research; issues letter to shareholders
Filed federal lawsuit against Viceroy Research seeking injunctive relief, disgorgement, and damages for defamation, conspiracy, and tortious interference.
MPT reports Q4 net loss of $0.24 per share; $171M impairment on Prospect properties
Q4 2022 net loss of ($0.24) per diluted share; full-year net income $1.50 per share, up 35% YoY.
MPT Q3 EPS $0.37, NFFO $0.45; raises net income guidance, tightens NFFO range
Q3 net income $222M ($0.37/sh) vs $171M ($0.29) YoY; NFFO $272M ($0.45) vs $263M ($0.44).
Medical Properties Trust authorizes $500M stock buyback through Oct 2023
Board authorized repurchase of up to $500M of common stock through Oct 10, 2023.
Medical Properties Trust Q2 net income $0.32 per share; NFFO $0.46, up 7% YoY; guidance maintained
Net income of $190M ($0.32/diluted share) vs $115M ($0.19) a year ago; NFFO $275M ($0.46) vs $251M ($0.43).
Medical Properties Trust enters $2.0B credit facility with $1.8B revolver and $200M term loan
$1.8B unsecured revolving facility and $200M unsecured term loan; total capacity up to $3B with incremental commitments.
MPT Q1 net income $1.05/sh, NFFO $0.47/sh (+12% YoY); dividend raised 4%
Net income of $632M ($1.05 diluted EPS) vs $164M ($0.28) a year ago; NFFO $0.47/sh, up 12% YoY.
Transaction values eight Massachusetts hospitals at ~$1.7B; MAM acquires 50% interest, MPT retains 50%.
MPT Q4 net income $0.34, NFFO $0.47 per share; full-year NFFO $1.75, guidance $1.81-$1.85
Q4 net income $0.34 per diluted share (up from $0.20); Normalized FFO (NFFO) $0.47 (up from $0.41).
MPT Q3 net income $0.29/sh, NFFO $0.44/sh; announces $1.5B capital transactions
Net income of $171M ($0.29 diluted) vs $131M ($0.25) YoY; NFFO $263M ($0.44) vs $221M ($0.41).
On February 16, 2023, Emmett E. McLean notified the Board of Directors (the “Board”) of Medical Properties Trust, Inc. (the “Company”) of his intent to retire as Executive Vice President, Chief Operating Officer, and Secretary of the Company, effective September 1, 2023.
On February 17, 2022, the board of directors (the “Board”) of Medical Properties Trust, Inc. (the “Company”), upon unanimous recommendation of the Ethics, Nominating and Corporate Governance Committee of the Board, appointed Emily W. Murphy as a member of the Board effective as of the same day.
Max materiality 0.90 · Median 0.70 · Most common event earnings